Medlive Technology Co Ltd
HKEX:2192
Relative Value
The Relative Value of one Medlive Technology Co Ltd stock under the Base Case scenario is 2.82 HKD. Compared to the current market price of 8.78 HKD, Medlive Technology Co Ltd is Overvalued by 68%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
Competitors Multiples
Medlive Technology Co Ltd Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
CN |
Medlive Technology Co Ltd
HKEX:2192
|
6.4B HKD | 14.3 | 24.3 | 5.7 | 5.9 | ||
US |
Veeva Systems Inc
NYSE:VEEV
|
32.9B USD | 13.9 | 62.5 | 62.6 | 67.3 | ||
US |
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 4.8 | 47.3 | 19.6 | 38.6 | ||
US |
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 2.6 | -116.8 | 16.5 | 111.6 | ||
AU |
Pro Medicus Ltd
ASX:PME
|
11.8B AUD | 80.8 | 169.5 | 116.5 | 116.5 | ||
JP |
M3 Inc
TSE:2413
|
1.2T JPY | 4.9 | 24.9 | 13 | 14.6 | ||
US |
Inspire Medical Systems Inc
NYSE:INSP
|
7.4B USD | 11.9 | -350.7 | -185.9 | -172.8 | ||
US |
Doximity Inc
NYSE:DOCS
|
4.5B USD | 9.7 | 33 | 22.1 | 23.5 | ||
SE |
Sectra AB
STO:SECT B
|
43B SEK | 26.3 | 101.3 | -66.1 | -66.1 | ||
US |
Evolent Health Inc
NYSE:EVH
|
3.1B USD | 1.6 | -21.8 | 25.7 | 274 | ||
US |
Goodrx Holdings Inc
NASDAQ:GDRX
|
3B USD | 4 | -339.5 | 35.9 | -117.4 |